tiprankstipranks
Trending News
More News >
United Therapeutics Corp. (UTHR)
NASDAQ:UTHR
US Market

United Therapeutics (UTHR) Income Statement

Compare
692 Followers

United Therapeutics Income Statement

Last quarter (Q4 2025), United Therapeutics's total revenue was $790.20M, an increase of 7.38% from the same quarter last year. In Q4, United Therapeutics's net income was $364.30M. See United Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.18B$ 2.88B$ 2.33B$ 1.94B$ 1.69B
Gross Profit
$ 2.80B$ 2.57B$ 2.07B$ 1.79B$ 1.56B
Operating Expenses
$ 1.31B$ 1.19B$ 885.10M$ 809.90M$ 1.01B
Depreciation and Amortization
$ 85.60M$ 72.50M$ 53.20M$ 51.30M$ 49.90M
EBITDA
$ 1.82B$ 1.65B$ 1.39B$ 1.04B$ 736.80M
Operating Income
$ 1.49B$ 1.38B$ 1.18B$ 979.70M$ 555.90M
Other Income/Expenses
$ 221.40M$ 162.00M$ 89.40M$ -29.10M$ 38.00M
Pretax Income
$ 1.71B$ 1.54B$ 1.27B$ 950.60M$ 593.90M
Net Income
$ 1.33B$ 1.20B$ 984.80M$ 727.30M$ 475.80M
Per Share Metrics
Basic EPS
$ 30.13$ 26.44$ 21.04$ 15.98$ 10.60
Diluted EPS
$ 27.86$ 24.64$ 19.81$ 15.00$ 10.06
Weighted Average Shares Outstanding
44.30M 45.20M 46.80M 45.50M 44.90M
Weighted Average Shares Outstanding (Diluted)
47.90M 48.50M 49.70M 48.50M 47.30M
Currency in USD

United Therapeutics Earnings and Revenue History